Cartesian Therapeutics, Inc. financial data

Symbol
RNAC on Nasdaq
Industry
Pharmaceutical Preparations
Location
704 Quince Orchard Rd, Gaithersburg, MD
State of incorporation
DE
Fiscal year end
December 31
Former names
SELECTA BIOSCIENCES INC (to 11/13/2023)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 276 % -49.2%
Debt-to-equity -231 % -330%
Return On Equity 154 %
Return On Assets -84.7 % -286%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21.4M shares -86.1%
Common Stock, Shares, Outstanding 17.8M shares -88.4%
Entity Public Float 129M USD -14%
Common Stock, Value, Issued 2K USD -86.7%
Weighted Average Number of Shares Outstanding, Basic 16.7M shares +227%
Weighted Average Number of Shares Outstanding, Diluted 17.8M shares +248%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 33.4M USD +537%
Revenue from Contract with Customer, Excluding Assessed Tax 53.9M USD +10.8%
Research and Development Expense 57.8M USD -19.6%
General and Administrative Expense 45.3M USD +89.4%
Operating Income (Loss) -49M USD -3.98%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9M USD -9.59%
Income Tax Expense (Benefit) -321K USD -102%
Net Income (Loss) Attributable to Parent -230M USD -555%
Earnings Per Share, Basic -5.11 USD/shares +21.6%
Earnings Per Share, Diluted -5.15 USD/shares +20.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 87.2M USD -22.1%
Accounts Receivable, after Allowance for Credit Loss, Current 32M USD +495%
Assets, Current 125M USD +1.68%
Property, Plant and Equipment, Net 6.67M USD +157%
Operating Lease, Right-of-Use Asset 13.9M USD +28.6%
Goodwill 48.2M USD
Assets 348M USD +149%
Accounts Payable, Current 2.86M USD +972%
Employee-related Liabilities, Current 1.4M USD -52.9%
Accrued Liabilities, Current 10.6M USD -17.7%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 26.1M USD -11.1%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 15.9M USD
Operating Lease, Liability, Noncurrent 12.3M USD +34.7%
Liabilities 449M USD +507%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.59M USD +0.11%
Retained Earnings (Accumulated Deficit) -658M USD -53.7%
Stockholders' Equity Attributable to Parent -101M USD -255%
Liabilities and Equity 348M USD +149%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.9M USD -81.6%
Net Cash Provided by (Used in) Financing Activities 43M USD +28780%
Net Cash Provided by (Used in) Investing Activities -602K USD -102%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 17.8M shares -88.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 26.5M USD +36%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 88.9M USD -22.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 124M USD -2.76%
Deferred Tax Assets, Gross 152M USD +16.3%
Operating Lease, Liability 14.9M USD +36.5%
Depreciation 700K USD -12.5%
Payments to Acquire Property, Plant, and Equipment 602K USD +363%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -230M USD -553%
Lessee, Operating Lease, Liability, to be Paid 20M USD +45.4%
Property, Plant and Equipment, Gross 12.7M USD +55.5%
Operating Lease, Liability, Current 2.52M USD +45.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.47M USD +58.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.35M USD +58.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +20.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.12M USD +79.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.28M USD +47.3%
Deferred Tax Assets, Operating Loss Carryforwards 29.8M USD +75.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 9.82M shares -1.81%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.24M USD -25%
Operating Lease, Payments 761K USD +16.5%
Additional Paid in Capital 561M USD +12.6%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 22.7M USD +108%
Interest Expense 2.03M USD -35.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%